Application 761041
- Type
- BLA
- Sponsor
- GENENTECH INC
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | TECENTRIQ | ATEZOLIZUMAB | INJECTABLE; INJECTION | 1200MG/20ML | No | No |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
NDC listings for this application page 1 of 1 ยท 1 matching rows.
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 50242-918 | TECENTRIQ | atezolizumab | Genentech, Inc. | BLA | Current |
Documents#
Document, Submission type, Date table| Document | Submission type | Date |
|---|
| 46566 | ORIG | 2016-12-27 |
| 46565 | ORIG | 2016-12-27 |
| 45959 | ORIG | 2016-11-28 |
| 45632 | ORIG | 2016-10-20 |
| 45626 | ORIG | 2016-10-18 |